dc.contributor.author |
Bayer, Melanie |
|
dc.contributor.author |
Schmitt, Julia |
|
dc.contributor.author |
Handgretinger, Rupert |
|
dc.contributor.author |
Bruchelt, Gernot |
|
dc.contributor.author |
Dittmann, Helmut |
|
dc.contributor.author |
Sauter, Alexander Walter |
|
dc.date.accessioned |
2019-01-22T08:01:22Z |
|
dc.date.available |
2019-01-22T08:01:22Z |
|
dc.date.issued |
2016 |
|
dc.identifier.issn |
1872-9614 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/85829 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Elsevier Science Inc |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.nucmedbio.2016.05.013 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Improved selectivity of mIBG uptake into neuroblastoma cells in vitro and in vivo by inhibition of organic cation transporter 3 uptake using clinically approved corticosteroids |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20180405102126_01505 |
|
utue.publikation.seiten |
543-551 |
de_DE |
utue.personen.roh |
Bayer, Melanie |
|
utue.personen.roh |
Schmitt, Julia |
|
utue.personen.roh |
Dittmann, Helmut |
|
utue.personen.roh |
Handgretinger, Rupert |
|
utue.personen.roh |
Bruchelt, Gernot |
|
utue.personen.roh |
Sauter, Alexander W. |
|
dcterms.isPartOf.ZSTitelID |
Nuclear Medicine and Biology |
de_DE |
dcterms.isPartOf.ZS-Issue |
9 |
de_DE |
dcterms.isPartOf.ZS-Volume |
43 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |